Inspire Medical Systems, Inc. (INSP)
NYSE
Price as at 1 Oct 2026, 07:18 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Inspire Medical Systems, Inc. trades at $69.36. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
7 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$80.94M · 0.0% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$65.60M · 0.0% of book
- Ken Griffin, CITADEL ADVISORS LLC$22.59M · 0.0% of book
- Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$19.00M · 0.0% of book
- Paul Tudor Jones, TUDOR INVESTMENT CORP ET AL$7.54M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in INSP
Trades in INSP disclosed by members of Congress and executive-branch officials, latest first:
- Daniel Goldman · HouseSell · $1,001 - $15,000 · traded 10 Apr 2023 · disclosed 19 May 2023
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
Common questions
Which funds own INSP?
7 of the institutions we track reported a position in INSP in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its INSP data?
Fundamentals for INSP come from company filings and exchange data, as listed on NYSE; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 07:18 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for INSP, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.